摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8-Dihydro-6H-Dipyrido[1,2-a:2',1'-c][1,4]diazepinediium dibromide | 2895-98-9

中文名称
——
中文别名
——
英文名称
7,8-Dihydro-6H-Dipyrido[1,2-a:2',1'-c][1,4]diazepinediium dibromide
英文别名
7,11-diazoniatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaene;dibromide
7,8-Dihydro-6H-Dipyrido[1,2-a:2',1'-c][1,4]diazepinediium dibromide化学式
CAS
2895-98-9
化学式
C13H14Br2N2
mdl
——
分子量
358.07
InChiKey
BMFRJCKQKSXVET-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -4.66
  • 重原子数:
    17
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    7.8
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME
    申请人:KH NEOCHEM CO., LTD.
    公开号:US20130123494A1
    公开(公告)日:2013-05-16
    The present invention provides a complex compound, etc., which has superior moisture- and heat-resistances, etc. and is used for an optical recording medium, including: a compound represented by Formula (I) below [in the formula, R 1 represents an alkyl group which may have one or more substituents, etc., R 2 represents a cyano group, etc., R 3 represents an alkyl group which may have one or more substituents, etc., R 4 represents a hydrogen atom, etc., R 5 represents Formula (III) (in the formula, the ring A represents a heterocycle which may have one or more substituents, wherein the heterocycle is any one selected from a pyrimidine ring, a tetrazole ring, etc.)]; a metal; and any one ion selected from the group consisting of an ion formed by addition of one or more protons to an amine, an ammonium ion and a quaternary ammonium ion.
    本发明提供了一种具有优越的湿热性能等特性的复合物等,用于光记录介质,包括:下式中所表示的化合物(在该式中,R1代表一个可能具有一个或多个取代基的烷基基团等,R2代表一个基等,R3代表一个可能具有一个或多个取代基的烷基基团等,R4代表一个氢原子等,R5代表下式(III)(在该式中,环A代表一个可能具有一个或多个取代基的杂环,其中该杂环是从嘧啶环、四唑环等中任选的任一环)];一种属;以及从由一个或多个质子加到胺上形成的离子、离子和季离子组成的群体中选择的任一离子。
  • Process for producing N-Phosphonomethylglycine
    申请人:MONSANTO COMPANY
    公开号:EP0412074A2
    公开(公告)日:1991-02-06
    A process for the production of N-phosphono­methylglycine comprising contacting N-phosphonomethyl­iminodiacetic acid with a molecular oxygen-containing gas in the presence of a catalyst selected from the group consisting of the salts and salt complexes of manganese, cobalt, iron, nickel, chromium, ruthenium, aluminum, molybdenum, vanadium and cerium, and an effective amount of a dipyridyl compound.
    一种生产 N-膦酰甲基甘酸的工艺,包括在一种催化剂存在下,使 N-膦酰甲基亚氨基二乙酸与含氧分子气体接触,该催化剂选自由、铝、的盐和盐络合物以及有效量的二吡啶化合物组成的组。
  • Processs for producing N-phosphonomethylglycine
    申请人:MONSANTO COMPANY
    公开号:EP0483098A1
    公开(公告)日:1992-04-29
    A process for the production of N-phosphonomethylglycine comprising contacting N-phosphonomethyliminodiacetic acid with a peroxide in the presence of a catalyst selected from the group consisting of the salts and salt complexes of cobalt and vanadium, and an effective amount of dipyridyl compound.
    一种生产 N-膦酰甲基甘酸的工艺,包括在选自的盐及盐络合物组成的催化剂和有效量的二吡啶化合物的存在下,使 N-膦酰甲基亚氨基二乙酸与过氧化物接触。
  • US4952723A
    申请人:——
    公开号:US4952723A
    公开(公告)日:1990-08-28
  • US5061820A
    申请人:——
    公开号:US5061820A
    公开(公告)日:1991-10-29
查看更多

同类化合物

氯吡卓醇 利喷西平 丙吡西平 N-[(4-苯基-2,3,4,5-四氢-1H-吡啶并[2,3-b][1,4]二氮杂卓-2-基)甲基]苯甲酰胺 N-[(4-苯基-2,3,4,5-四氢-1H-吡啶并[2,3-b][1,4]二氮杂卓-2-基)甲基]乙酰胺 9-叠氮基-11-乙基-6-甲基吡啶并[3,2-c][1,5]苯并二氮杂卓-5-酮 5-甲基-11-(甲磺酰)-5,11-二氢-6H-二吡啶并[3,2-b:2',3'-e][1,4]重氮基庚英-6-酮 5,11-二氢-4-甲基-6H-二吡啶并[3,2-b:2',3'-e][1,4]二氮杂卓-6-酮 4-苯基-2-氧代-5-(2-(4-甲基哌嗪-1-基)乙酰基)-1H-四氢吡啶并[2,3-b][1,4]二氮杂卓 4-苯基-1,3,4,5-四氢-2H-吡啶并[2,3-b][1,4]二氮杂卓-2-硫酮 4-(吗啉-4-基甲基)-1H-吡啶并[2,3-e][1,4]二氮杂卓-2,3,5(4H)-三酮 4,5-二氢-1H-吡啶并[2,3-E][1,4]重氮基庚英-3(2H)-酮 3-苯基-2-氧代-5-(2-(4-甲基哌嗪-1-基)乙酰基)-1H-四氢吡啶并[2,3-b][1,4]二氮杂卓 3-(乙酰氧基)-7-氯-5-(2-氯苯基)-1,3-二氢-2H-吡啶并[3,2-e]-1,4-二氮杂卓-2-酮 3,4,6,7-四氢-10-氯-1-苯基-8H-吡啶并[3,2,1-jk][1,4]苯并二氮杂卓-4,8-二酮 2-甲基-5-(2-吗啉-4-基乙基)-3,5-二氢-4H-吡啶并[2,3-b][1,4]重氮基庚英-4-酮盐酸 1OH-吡啶并(3,2-d)噻吩并(3,2-e)(1,4)-重氮基庚英-10-酮,4,9-二氢-4-((4-甲基-1-哌嗪基)乙酰基)-,盐酸盐 11-(N-甲基六氢烟酰基)-6,11-二氢-5H-吡啶并(2,3-b)-1,5-苯并二氮杂卓-5-酮 1-(5-甲基-3,4-二氢-2H-吡啶并[2,3-B] [1,4]二氮杂-1-基)乙酮 7-chloro-5-phenyl-1,5-dihydro-pyrido[2,3-b][1,4]diazepine-2,4-dione Ethyl-thieno[3,2-b]pyrrolizin-(4Z)-ylidene-amine 7-chloro-5-(2-chloro-phenyl)-3-hydroxy-1-methyl-1,3-dihydro-pyrido[3,2-e][1,4]diazepin-2-one II(ss-morpholinoethyl,8-Me,9-Me) 4-Benzyl-2-thioxo-3,4-dihydro-1H-pyrido[2,3-e][1,4]diazepin-5(2H)-one 3-acetoxy-1-acetyl-7-chloro-5-(2-chloro-phenyl)-1,3-dihydro-pyrido[3,2-e][1,4]diazepin-2-one 4-benzyl-2-(pyrrolidin-1-yl)-3H-pyrido[3,2-e][1,4]diazepin-5(4H)-one 4,5-dimethyl-2-phenyl-11H-pyrido[3,2-b]pyrimido[4,5-e][1,4]diazepine 4,5-Dihydro-4[5-(trifluoromethanesulfonamido)pentan-1-yl]-3H-1,4,8b-triazaacenaphthylen-5-one 5-(3-chloro-2-fluoro-phenyl)-4-(4-fluoro-phenyl)-3-isopropyl-2-(3-methyl-butyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one 3-allyl-5,8-di-morpholin-4-yl-2-phenyl-3,4-dihydro-pyrimido[4,5-d]pyridazine II(ss-morpholinoethyl,H,H) 1,8-dimethyl-1,2,3,4-tetrahydro-5H-pyrido[2,3-e][1,4]diazepin-5-one (7R)-7-benzyl-8-[5-fluoro-2-(trifluoromethoxy)phenyl]sulfonyl-2,5,8,11,13-pentazatricyclo[8.4.0.02,6]tetradeca-1(14),3,5,10,12-pentaene 7-fluoro-3-isobutyl-4-[(isoquinolin-5-yloxy)acetyl]-3,4-dihydroquinoxalin-2(1H)-one 1-acetyl-7-chloro-5-phenyl-1,3-dihydro-pyrido[3,2-e][1,4]diazepin-2-one 7-Benzyl-8-[2-(trifluoromethoxy)phenyl]sulfonyl-2,5,8,14-tetrazatricyclo[8.4.0.02,6]tetradeca-1(10),3,5,11,13-pentaene 4-benzyl-7-bromo-8-methyl-1,2,3,4-tetrahydro-pyrido[2,3-e][1,4]diazepin-5-one 4-isopropoxycarbonyl-3-(R,S)-phenyl-3,4-dihydro-1,4,5-triazanaphthalen-2(1H)-one 7-chloro-2-oxo-5-phenyl-2,3-dihydro-pyrido[3,2-e][1,4]diazepine-1-carboxylic acid ethylamide 4-benzyl-3,4-dihydro-1H-pyrido[2,3-e][1,4]diazepine-2,5-dione 3-{2-cyclohexyl-4-[6-(2-hydroxyethylamino)pyridine-3-sulfonyl]-6-oxopiperazin-1-yl}-5-phenylthiophene-2-carboxylic acid 3-(3-chlorothien-2-yl)-5-(2-furyl)-1,3-dihydro-2H-pyrido[2,3-e][1,4]diazepin-2-one 3-ethyl-7-fluoro-4-[(isoquinolin-5-yloxy)acetyl]-3,4-dihydroquinoxalin-2(1H)-one 3,3'-dimethyl-2,2'-bis(methylthio)-3H-spiro[pyrimido[4,5-b]quinoline-5,5'-pyrrolo[2,3-d]pyrimidine]-4,4',6'(3'H,7'H,10H)-trione (7R)-7-benzyl-8-[2-(trifluoromethoxy)phenyl]sulfonyl-2,5,8,11,14-pentazatricyclo[8.4.0.02,6]tetradeca-1(14),3,5,10,12-pentaene 5-(2-furyl)-3-(1-methyl-1H-pyrrol-2-yl)-1,3-dihydro-2H-pyrido[2,3-e][1,4]diazepin-2-one 4-benzyl-8-methyl-1,2,3,4-tetrahydro-pyrido[2,3-e][1,4]diazepin-5-one 3,5-di-2-furyl-1,3-dihydro-2H-pyrido[2,3-e][1,4]diazepin-2-one 7-chloro-5-phenyl-1,3-dihydro-pyrido[3,2-e][1,4]diazepin-2-one acetylhydrazone 1,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepine